Yuri Nikolsky

Asociate Professor

University of Sharjah

Yuri Nikolsky, Ph.D., MBA Dr. Nikolsky is a distinguished scientist and entrepreneur specializing in biomedicine and healthcare. He currently serves as an Associate Professor at the College of Medicine, University of Sharjah, UAE, and a Visiting Professor at AREVA Research Institute in San Antonio, TX, USA. Additionally, he is a co-founder of a longevity-focused real estate consulting company in Dubai, UAE. As a scientist, Dr. Nikolsky has an h-index of 53, has authored two books, and has published over 100 scientific and business articles. With more than 20 years of experience as an entrepreneur and executive, he has led research, product development, and business initiatives in the life sciences industry and innovation funds. His expertise spans preclinical small-molecule drug discovery, systems biology, computational biology, translational medicine, and regenerative medicine. Dr. Nikolsky has co-founded several successful ventures, including: • Integrated Genomics (Chicago, IL, USA) – The world’s first commercial DNA sequencing company. • GeneGo (San Diego, CA, USA) – A pioneering systems biology and AI company, later acquired by Thomson Reuters, where he served as Vice President of R&D, leading computational biology research with global pharmaceutical firms. • MiLabs (San Diego, CA, USA) – The “best in class” personal immunology company. • Santa Maria (Baja California, Mexico) – A holistic medicine center focused on chronic diseases, longevity medicine, and biohacking. Additionally, Dr. Nikolsky served as CEO at ChemDiv, a leading pharmaceutical CRO in San Diego, CA, USA. His contributions to biomedical research, AI-driven drug discovery, and longevity science continue to shape the future of healthcare innovation.